Companies / United Kingdom
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Treatment Shortfall Remains For Depression
March 2007 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
According to a report from the Association of the British Pharmaceutical Industry, the availability of more effective drugs with fewer side effects, coupled with a better understanding of the route causes of depression, is improving the treatment for this condition. Even though, a recent survey has suggested that 50% of people with depression in the UK are still not receiving any type of treatment.